Cargando…
Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
HIV-1 envelope (Env) N-glycosylation impact virus-cell entry and immune evasion. How each glycan interacts to shape the Env-protein-sugar complex and affects Env function is not well understood. Here, analysis of two Env variants from the same donor, with differing functional characteristics and N-g...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649354/ https://www.ncbi.nlm.nih.gov/pubmed/33205023 http://dx.doi.org/10.1016/j.isci.2020.101711 |
_version_ | 1783607308572426240 |
---|---|
author | Wei, Qing Hargett, Audra A. Knoppova, Barbora Duverger, Alexandra Rawi, Reda Shen, Chen-Hsiang Farney, S. Katie Hall, Stacy Brown, Rhubell Keele, Brandon F. Heath, Sonya L. Saag, Michael S. Kutsch, Olaf Chuang, Gwo-Yu Kwong, Peter D. Moldoveanu, Zina Raska, Milan Renfrow, Matthew B. Novak, Jan |
author_facet | Wei, Qing Hargett, Audra A. Knoppova, Barbora Duverger, Alexandra Rawi, Reda Shen, Chen-Hsiang Farney, S. Katie Hall, Stacy Brown, Rhubell Keele, Brandon F. Heath, Sonya L. Saag, Michael S. Kutsch, Olaf Chuang, Gwo-Yu Kwong, Peter D. Moldoveanu, Zina Raska, Milan Renfrow, Matthew B. Novak, Jan |
author_sort | Wei, Qing |
collection | PubMed |
description | HIV-1 envelope (Env) N-glycosylation impact virus-cell entry and immune evasion. How each glycan interacts to shape the Env-protein-sugar complex and affects Env function is not well understood. Here, analysis of two Env variants from the same donor, with differing functional characteristics and N-glycosylation-site composition, revealed that changes to key N-glycosylation sites affected the Env structure at distant locations and had a ripple effect on Env-wide glycan processing, virus infectivity, antibody recognition, and virus neutralization. Specifically, the N262 glycan, although not in the CD4-binding site, modulated Env binding to the CD4 receptor, affected Env recognition by several glycan-dependent neutralizing antibodies, and altered site-specific glycosylation heterogeneity, with, for example, N448 displaying limited glycan processing. Molecular-dynamic simulations visualized differences in glycan density and how specific oligosaccharide positions can move to compensate for a glycan loss. This study demonstrates how changes in individual glycans can alter molecular dynamics, processing, and function of the Env-glycan shield. |
format | Online Article Text |
id | pubmed-7649354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-76493542020-11-16 Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies Wei, Qing Hargett, Audra A. Knoppova, Barbora Duverger, Alexandra Rawi, Reda Shen, Chen-Hsiang Farney, S. Katie Hall, Stacy Brown, Rhubell Keele, Brandon F. Heath, Sonya L. Saag, Michael S. Kutsch, Olaf Chuang, Gwo-Yu Kwong, Peter D. Moldoveanu, Zina Raska, Milan Renfrow, Matthew B. Novak, Jan iScience Article HIV-1 envelope (Env) N-glycosylation impact virus-cell entry and immune evasion. How each glycan interacts to shape the Env-protein-sugar complex and affects Env function is not well understood. Here, analysis of two Env variants from the same donor, with differing functional characteristics and N-glycosylation-site composition, revealed that changes to key N-glycosylation sites affected the Env structure at distant locations and had a ripple effect on Env-wide glycan processing, virus infectivity, antibody recognition, and virus neutralization. Specifically, the N262 glycan, although not in the CD4-binding site, modulated Env binding to the CD4 receptor, affected Env recognition by several glycan-dependent neutralizing antibodies, and altered site-specific glycosylation heterogeneity, with, for example, N448 displaying limited glycan processing. Molecular-dynamic simulations visualized differences in glycan density and how specific oligosaccharide positions can move to compensate for a glycan loss. This study demonstrates how changes in individual glycans can alter molecular dynamics, processing, and function of the Env-glycan shield. Elsevier 2020-10-21 /pmc/articles/PMC7649354/ /pubmed/33205023 http://dx.doi.org/10.1016/j.isci.2020.101711 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Wei, Qing Hargett, Audra A. Knoppova, Barbora Duverger, Alexandra Rawi, Reda Shen, Chen-Hsiang Farney, S. Katie Hall, Stacy Brown, Rhubell Keele, Brandon F. Heath, Sonya L. Saag, Michael S. Kutsch, Olaf Chuang, Gwo-Yu Kwong, Peter D. Moldoveanu, Zina Raska, Milan Renfrow, Matthew B. Novak, Jan Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies |
title | Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies |
title_full | Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies |
title_fullStr | Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies |
title_full_unstemmed | Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies |
title_short | Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies |
title_sort | glycan positioning impacts hiv-1 env glycan-shield density, function, and recognition by antibodies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649354/ https://www.ncbi.nlm.nih.gov/pubmed/33205023 http://dx.doi.org/10.1016/j.isci.2020.101711 |
work_keys_str_mv | AT weiqing glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT hargettaudraa glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT knoppovabarbora glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT duvergeralexandra glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT rawireda glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT shenchenhsiang glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT farneyskatie glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT hallstacy glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT brownrhubell glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT keelebrandonf glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT heathsonyal glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT saagmichaels glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT kutscholaf glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT chuanggwoyu glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT kwongpeterd glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT moldoveanuzina glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT raskamilan glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT renfrowmatthewb glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies AT novakjan glycanpositioningimpactshiv1envglycanshielddensityfunctionandrecognitionbyantibodies |